- Home
- SRDX vs SIGA Comparison
SRDX vs SIGA Comparison
Compare SRDX & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRDX
- SIGA
- Stock Information
- Founded
- SRDX 1979
- SIGA 1995
- Country
- SRDX United States
- SIGA United States
- Employees
- SRDX N/A
- SIGA N/A
- Industry
- SRDX Medical/Dental Instruments
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- SRDX Health Care
- SIGA Health Care
- Exchange
- SRDX Nasdaq
- SIGA Nasdaq
- Market Cap
- SRDX 415.4M
- SIGA 422.9M
- IPO Year
- SRDX 1998
- SIGA 1997
- Fundamental
- Price
- SRDX $30.91
- SIGA $6.77
- Analyst Decision
- SRDX Buy
- SIGA
- Analyst Count
- SRDX 2
- SIGA 0
- Target Price
- SRDX $43.00
- SIGA N/A
- AVG Volume (30 Days)
- SRDX 92.6K
- SIGA 388.3K
- Earning Date
- SRDX 07-30-2025
- SIGA 07-31-2025
- Dividend Yield
- SRDX N/A
- SIGA 8.70%
- EPS Growth
- SRDX N/A
- SIGA N/A
- EPS
- SRDX N/A
- SIGA 0.67
- Revenue
- SRDX $121,575,000.00
- SIGA $120,330,310.00
- Revenue This Year
- SRDX N/A
- SIGA N/A
- Revenue Next Year
- SRDX $3.70
- SIGA $95.31
- P/E Ratio
- SRDX N/A
- SIGA $10.09
- Revenue Growth
- SRDX N/A
- SIGA N/A
- 52 Week Low
- SRDX $26.00
- SIGA $4.95
- 52 Week High
- SRDX $42.25
- SIGA $12.83
- Technical
- Relative Strength Index (RSI)
- SRDX 65.27
- SIGA 61.28
- Support Level
- SRDX $29.51
- SIGA $6.34
- Resistance Level
- SRDX $31.06
- SIGA $7.07
- Average True Range (ATR)
- SRDX 0.91
- SIGA 0.22
- MACD
- SRDX 0.18
- SIGA 0.02
- Stochastic Oscillator
- SRDX 86.61
- SIGA 71.70
About SRDX Surmodics Inc.
Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.